On the one hand, the loss of FBP1 promotes tumor progression by enhancing glycolysis and accelerating cancer cells growth, thereby leading to a poor prognosis in patients with breast cancer, pancreatic cancer and liver cancer. The gene discussed is FBP1; the disease is neoplasm.